Ciaran M. Considine, PhD, ABPP-CN

Ciaran M. Considine, PhD, ABPP-CN

Park Dietz & Associates, Inc., a nationwide, interdisciplinary forensic expert firm
2906 Lafayette Rd.
Newport Beach, CA 92663
Office: 949-723-2211
Introduction

Ciaran Michael Considine, PhD, ABPP-CN, is an Associate Professor of Neurology at Vanderbilt University School of Medicine and a board-certified clinical neuropsychologist within the associated Vanderbilt University Medical Center.

Dr. Considine earned his undergraduate degree at the University of Michigan and graduate degree from the University of Windsor. Subsequently, he completed internship residency at the Detroit VA Medical Center, and then concurrently finished his training as a postdoctoral resident fellow at the Milwaukee VA Medical center and postdoctoral visiting fellow at the Medical College of Wisconsin.

Dr. Considine has been a Forensic Expert with Park Dietz & Associates since 2020. He fields civil cases for both plaintiffs and defendants and criminal cases for both defense counsel and prosecutors. Additionally, he performs administrative fitness-for-duty evaluations for pilots in accordance with FAA guidelines as well as physicians following field standards.


Areas of Expertise
  • Competency
  • Fitness for Duty Evaluation
  • Independent Medical Examinations
  • Malingering
  • Mass Torts
  • Neuropsychology
  • Personal Injury
  • Sanity/Competency to Stand Trial
  • Testamentary Capacity

Expert Background
Q: Please list your professional accreditations, degrees, licenses, and certificates granted:
A:
• BA with High Honors (Psychology) – University of Michigan (Ann Arbor, MI)
• PhD (Clinical Psychology, Neuropsychology track) – University of Windsor (Windsor, ON)

Licensure and Certification:
• Licensed Psychologist, Tennessee Board of Examiners of Psychology
• Diplomate, American Academy of Clinical Neuropsychology, American Board of Professional Psychology
Q: Please list your affiliations or memberships in any professional and/or industry organizations:
A:
• International Neuropsychological Society
• National Academy of Neuropsychology
• Society for Clinical Neuropsychology (Division 40, APA)
• American Academy of Clinical Neuropsychology
• Tennessee Psychological Association
Q: Please list any teaching or speaking experience you have had, including subject matter:
A:
• Adjunct Instructor, Department of Psychology, Marquette University (2017)
• Assistant Professor, Department of Neurology, Vanderbilt University School of Medicine (2017–2023)
• Associate Professor, Department of Neurology, Vanderbilt University School of Medicine (2023–present)

Teaching Activities:
Graduate School Courses
• Marquette University, Course Instructor
Neuropsychological Assessment (PSYC 8975) (Fall 2017)
• Vanderbilt University, Guest Lecturer
Understanding Neurodegenerative Disorders (NSC3891), Lewy Body Dementia (10/2023)

Medical School Courses
• Vanderbilt University School of Medicine, Course Faculty
Ecology and Health: Climate, Food, and Justice (IDIS-5450) (Spring 2022)

Clinical Instruction
• Vanderbilt University Medical Center
• Lecturer, Neurology Residency Lecture Series
Neuropsychological Assessment Overview, Cognitive Neurology block (2018–2020)
Neurobehavioral Sequelae of Brain Tumor, Neuro-oncology block (2018–2020)
• Clinical Supervisor
Medical Student Clerkship, Cognitive Neurology rotation (2018–pres.)
Neuropsychology Fellowship (2021–pres.)
Junior Resident Clinic (2022–pres.)

Continuing Medical Education Lectures
• Vanderbilt University Medical Center
• Neurology, Sleep Division CME Lecture, “Sleep Disorders & Neurocognition” (7/2019)
• Psychiatry, Forensic Interest Group CE Session, “Criminal Behavior in Early-onset Dementia Syndromes” (6/2021)
• Psychiatry, Forensic Interest Group CE Session, “Heuristics and Interview Techniques for Delineating Mild TBI from More Substantial Neurological Injury” (2/2022)

Presentations:
Refereed/Peer-reviewed Presentations at Scientific Meetings
1. Parker HA, Considine CM, Briggs J, Quasney E, Larson ER, Smith H, Shollenbarger S, Abeare C. Evaluating the Moderating Role of Medical Comorbidity, Pain, and Depression on the Relationship Between Sleep Biomarkers and Cognitive Functioning in Obstructive Sleep Apnea. Paper presentation, International Neuropsychological Society, February 2018.
2. Darby C, Considine CM, Weinstock R, Darby R (chair). Evaluating Decision-Making Capacity in Neuropsychiatric Patients: Timing Matters. Seminar, Neuroethics Network, June 2019.
3. Donahue MJ, Hett K, McKnight CD, Eisma JJ, Elenberger J, Considine CM, Song A, Stark A, Claassen DO. CSF production and clearance across the lifespan: Re-interpreting CSF egress in aging and neurodegeneration. Oral abstract presentation, Brain & Brain PET, May 2022.
4. Ponzo T, Hett K, Eisma J, Elenberger J, Song A, McKnight C, Considine CM, Donahue M, Claassen D. Sleep quality associated with neuroimaging measures of CSF flow in individuals with Parkinson’s disease. Oral abstract presentation, in ‘Neuroscience in the Clinic: Can Sleep Prevent or Improve Neurologic Diseases?’ session, American Academy of Neurology, April 2023.
5. Hett K, McKnight C, Eisma J, Hernandez A, Leguizamon M, Elenberger J, Considine CM, Claassen D, Donahue M. MRI biomarkers of neurofluid production and egress provide support for aberrations in the neurofluid circuit in patients with Huntington’s disease. Oral abstract presentation, International Society for Magnetic Resonance in Medicine, June 2023.
6. Mays G, Hett K, Eisma JK, McKnight C, Elenberger J, Song A, Considine CM, Han C, Claassen D, Donahue M. DWI with dynamic b-value cycling reveals evidence of reduced suprasellar cistern neurofluid motion in Parkinson’s disease. Oral abstract presentation, International Society for Magnetic Resonance in Medicine, June 2023.
7. Puente A, Basso M, Whiteside D, Koterba C, Vargas G, Becker J, Considine CM, Hoskinson K. Neuropsychological Concomitants of Long COVID. Expert panel presentation, American Psychological Association, August, 2023.
8. Darby C, Choi O, Darby R, Considine CM. Telling the Whole Truth: Neurological Evidence in the Courtroom. American Academy of Psychiatry and the Law, October 2023.
9. Considine CM, Basso M, Whiteside D. Adult Neuropsychological Evaluation of Long COVID-19: Cognitive, Psychological, and Performance Validity Considerations. American Academy of Clinical Neuropsychology, June 2024.

Invited Presentations at Scientific Meetings
1. Glymphatic System and its Putative Clinical Relevance. Clinical Neurological Society of America, January 2020.
2. Anosognosia in Clinical Practice. Clinical Neurological Society of America, January 2020.
3. Considine CM, Rossetti A. Neuropsychology of Huntington Disease. Houston Neuropsychological Society’s Symposium, October 2021.
4. Clinical Diagnosis of Functional Cognitive Disorders: Advice from a Neuropsychologist. Clinical Neurological Society of America, January 2023.
5. Considine CM, Rossetti A. Neurocognitive Disorders in Pre(motor) Manifest Huntington Disease: A Neuropsychological Perspective on Huntington Disease & Case Study – The Aspiring Pilot. Huntington’s Disease Society of America, Southeast Symposium, February 2023.
6. Clinical Practice Guidance for Neuropsychological Evaluation in PASC/Long COVID & A Neuropsychometric Screening & Triage Model for use in PASC/Long COVID Clinics. BOUNCE: Bonn University Citizen Science COVID-19 Symposium, May 2023.
7. Neurobehavioral Manifestations of Huntington Disease: Assessment & Management Techniques. American Academy of Neurology, April 2023; KnowNeuropsychology Didactic Series, December 2024; UAB Neuropsychology & Cognitive Science Seminar Series, January 2024.

Invited External Grand Round Presentations
1. “A Neuropsychological Perspective on Sleep,” Neurology, University of Kentucky Medical School (2/2017)
2. “The Glymphatic System & Chronodegeneration” Neurology, Medical University of South Carolina (5/2022)

Internal Grand Round Presentations (all within Vanderbilt University Medical Center)
1. “A Neuropsychological Perspective on Sleep,” Neurology (3/2017)
2. “Chronodegeneration – Circadian dysfunction in neurodegenerative disease” Neurology (10/2019); Psychiatry (5/2020)
3. “Climate Change, the Environment, & Brain Health – How we can make a difference,” Neurology (10/2021)
4. “Clinical Diagnosis of Functional Cognitive Disorders,” Neurology (2023)
Q: Have any of your accreditations ever been investigated, suspended or removed? (if yes, explain)
A: No
Q: On how many occasions have you been retained as an expert?
A: ~25
Q: For what area(s) of expertise have you been retained as an expert?
A: Neuropsychological
Q: In what percentage of your cases were you retained by the plaintiff?
A: ~45%
Q: In what percentage of your cases were you retained by the defendant?
A: ~55%
Q: On how many occasions have you had your deposition taken?
A: 1
Q: When was the last time you had your deposition taken?
A: 8/2022
Q: On how many occasions have you been qualified by a court to give expert testimony?
A: 2
Q: For how many years have you worked with the legal industry as an expert?
A: 4 years
Q: What services do you offer? (E.g.: consulting, testing, reports, site inspections etc.)
A: Neuropsychological Evaluation and Report, Consulting, Record Review, Expert Testimony
Q: What is your hourly rate to consult with an attorney?
A: Hourly rates are the same for all activities and are available on request.
Q: What is your hourly rate to review documents?
A: Hourly rates are the same for all activities and are available on request.
Q: What is your hourly rate to provide deposition testimony?
A: Hourly rates are the same for all activities and are available on request.
Q: What is your hourly rate to provide testimony at trial?
A: Hourly rates are the same for all activities and are available on request.
Q: Please list any fees other than those stated above (E.g.: travel expenses, copy fees, etc.)
A: Travel expenses and other expenses specified in the engagement letter or contract.

References

Available Upon Request